As of August 28, 2026, Edgewise Therapeutics, Inc. (EWTX) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Edgewise Therapeutics, Inc. has a market capitalization of $3.68B, 108.60M shares outstanding, 218 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise
model 15%
• Under 12 months cash (7mo)
Market Data
Market Cap$3.68B
Shares Outstanding108.60M
Float67.12M
Cash$72.32M
Debt$66.0K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 14.5% shares (2026Q1 vs prior)
218 institutional holders · 141.38M shares
#1
ORBIMED ADVISORS LLC
15.52M shares
#2
JANUS HENDERSON GROUP PLC
11.83M shares
#3
RA CAPITAL MANAGEMENT, L.P.
10.43M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest9.84M
Days to Cover12.1
% of Float14.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2021-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual EWTX Dilution Snapshot
Edgewise Therapeutics, Inc. (EWTX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for EWTX: xbrl on 2021-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track EWTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EWTX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for EWTX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.